Wells Fargo’s Gain Therapeutics GANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.77K | Hold |
2,650
| – | – | ﹤0.01% | 5638 |
|
|
2025
Q1 | $5.06K | Hold |
2,650
| – | – | ﹤0.01% | 5559 |
|
|
2024
Q4 | $5.72K | Hold |
2,650
| – | – | ﹤0.01% | 5538 |
|
|
2024
Q3 | $4.72K | Hold |
2,650
| – | – | ﹤0.01% | 5515 |
|
|
2024
Q2 | $3.39K | Sell |
2,650
-1,106
| -29% | -$1.42K | ﹤0.01% | 5551 |
|
|
2024
Q1 | $14.2K | Buy |
3,756
+29
| +0.8% | +$109 | ﹤0.01% | 5275 |
|
|
2023
Q4 | $12.2K | Buy |
3,727
+4
| +0.1% | +$13 | ﹤0.01% | 5346 |
|
|
2023
Q3 | $12.2K | Buy |
3,723
+5
| +0.1% | +$16 | ﹤0.01% | 5382 |
|
|
2023
Q2 | $16.7K | Buy |
3,718
+5
| +0.1% | +$22 | ﹤0.01% | 5489 |
|
|
2023
Q1 | $17.9K | Buy |
3,713
+1
| +0% | +$5 | ﹤0.01% | 5360 |
|
|
2022
Q4 | $11.6K | Buy |
3,712
+1,001
| +37% | +$3.13K | ﹤0.01% | 5169 |
|
|
2022
Q3 | $9K | Buy |
2,711
+36
| +1% | +$120 | ﹤0.01% | 5391 |
|
|
2022
Q2 | $10K | Buy |
2,675
+2
| +0.1% | +$7 | ﹤0.01% | 5454 |
|
|
2022
Q1 | $11K | Buy |
2,673
+2,650
| +11,522% | +$10.9K | ﹤0.01% | 5880 |
|
|
2021
Q4 | $0 | Hold |
23
| – | – | ﹤0.01% | 6846 |
|
|
2021
Q3 | $0 | Sell |
23
-1
| -4% | – | ﹤0.01% | 6795 |
|
|
2021
Q2 | $0 | Buy |
+24
| New | – | ﹤0.01% | 6702 |
|